ACS management module 1: scope of the problem in the UK

Released 19 September 2017     Expires: 19 September 2019      Programme: ACS management 0.5 CPD/CME credit, 0.5 hours

Sponsorship Statement: AstraZeneca provided an arms-length grant to fund production of the supplement, on which this learning programme is based. AstraZeneca had no editorial input into the content other than a review for technical accuracy.

Designed to give healthcare professionals an understanding of the scope of the problem of acute coronary syndrome in the UK, with consideration of those at higher risk, and the high future risk of fatal and non-fatal cardiovascular events in survivors of myocardial infarction.

Learning objectives

After completing this module, participants should be better able to understand:

  • the definition of acute coronary syndrome
  • the rates of myocardial infarction in the UK and the associated survival and re-infarction rates
  • interventional strategies for the management of acute coronary syndrome (ACS)
  • how to determine who is at very high risk of re-infarction
  • the policies for the prevention of ACS events and how to implement them


Professor Chris P Gale, Professor of Cardiovascular Medicine, University of Leeds; Honorary Consultant Cardiologist, York Teaching Hospital

With thanks to Dr Kevin Cheng, Core Medical Trainee, London, for assistance on the self-assessment aspect of the programme


0.5 CPD/CME credit, 0.5 hours
BJC Learning has assigned half an hour of CPD/CME credit to this module

You need to login to take this module

You need to be a registered member to view this page. It's quick, free and offers you a host of other benefits, including the facility to print and download articles and supplements, access our archived issues and receive email updates when new issues and other content are online.

78 thoughts on “ACS management module 1: scope of the problem in the UK”

All rights reserved. No part of this programme may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publishers, Medinews (Cardiology) Limited.

It shall not, by way of trade or otherwise, be lent, re-sold, hired or otherwise circulated without the publisher’s prior consent.

Medical knowledge is constantly changing. As new information becomes available, changes in treatment, procedures, equipment and the use of drugs becomes necessary. The editors/authors/contributors and the publishers have taken care to ensure that the information given in this text is accurate and up to date. Readers are strongly advised to confirm that the information, especially with regard to drug usage, complies with the latest legislation and standards of practice.

Healthcare professionals should consult up-to-date Prescribing Information and the full Summary of Product Characteristics available from the manufacturers before prescribing any product. Medinews (Cardiology) Limited cannot accept responsibility for any errors in prescribing which may occur.